MeRes100™ | World First 100 Micron Biodegradable Scaffold

Biodegradable scaffold or Bioresorbable scaffolds (BRS) heralded the fourth revolution in interventional cardiology. They were ultimately designed to overcome the perceived limitations of DES by providing a temporary support to the vessel wall, whilst simultaneously allowing for the release of an anti-proliferative drug to limit the excessive response, in order to potentially allow the vessel to heal and restore its physiological function

MeRes100 BRS - the first thin-tip sirolimus releasing bioresorbable vascular matrix - shows positive long-term safety consistent with low cardiac event rates and zero matrix stent thrombosis for patients with coronary artery disease.

It fully resorbs naturally in the artery within 2-3 years, thus restoring the vessel to its true form and nature. The design of MeRes100™ scaffold addresses the limitations of the previous generation scaffold and in a true sense is the next revolution in bioresorbable technology

1)Next Generation BioResorbable Scaffold: World's first 100µm BVS.

2)Ideal strut thickness to minimize vascular injury & ensure early endothelialization.

3)Virtual Tubing: Couplets of tri-axial RO markers at either end of the scaffold.

4)Hybrid Stent Design: Strut width variability allows for adequate radial strength.

5)Future treatment possibilities: Restore the artery to natural state after resorption.